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Simultaneous endovascular treatment
of abdominal aortic aneurysm and renal artery
stenosis
Jednoczasowa wewnątrznaczyniowa operacja naprawcza tętniaka aorty brzusznej
i zwężenia tętnicy nerkowej
Streszczenie
Tętniak aorty brzusznej (AAA) często współwystępuje
ze zwężeniem tętnicy nerkowej (RAS). Wybór optymal-
nego postępowania terapeutycznego powinien być w ta-
kich okolicznościach zindywidualizowany. Leczenie we-
wnątrznaczyniowe AAA stało się akceptowalną alterna-
tywą dla operacji otwartych, a angioplastyka RAS prawie
całkowicie wyparła rewaskularyzację chirurgiczną. W ar-
tykule przedstawiono przypadek pacjenta z wysokim ry-
zykiem powikłań okołooperacyjnych oraz opornym nad-
ciśnieniem tętniczym, u którego wykonano skuteczną
wewnątrznaczyniową operację naprawczą AAA nieobej-
mującą tętnic nerkowych z jednoczasową angioplastyką
RAS z wszczepieniem stentu.
słowa kluczowe: zwężenie tętnicy nerkowej,
nadciśnienie, tętniak aorty brzusznej, stentgraft
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Introduction
Abdominal aortic aneurysms (AAA) are being dia-
gnosed with increasing frequency. A rupture of AAA
is the most feared, often fatal complication. Renova-
scular hypertension remains the most common form
of correctable hypertension and atherosclerotic renal
artery stenosis (RAS) is its most prevalent cause. Co-
existing of RAS and AAA has been identified in
33,1% [1]. The treatment of infrarenal AAA associa-
ted with atheromateous renal disease is challenging.
Both vascular pathologies may be managed by either
surgical or endovascular treatment. Endovascular repa-
ir of infrarenal AAA (EVAR) has become in recent years
a generally accepted alternative to open surgery [2, 3].
In treatment of RAS, percutaneous techniques have lar-
gely replaced surgical revascularization [4, 5].
We report a case when simultaneous endovascu-
lar treatment of RAS and infrarenal AAA was chosen
in management of patient with resistant hypertension,
renal dysfunction and cardiopulmonary disease.
Case raport
A 69-year old male with a history of arterial hy-
pertension, diabetes type 2, myocardial infarction,
COPD and atherosclerosis of lower extremities arte-
ries, was referred with asymptomatic AAA with dia-
meter of 57 mm in ultrasound and stenosis of the
proximal segment on left renal artery. Laboratory
studies showed slightly elevated creatinine —
144 µmol/l (normal 53–115 µmol/l), and glomerular fil-
tration rate (GFR) estimated by MDRD formula was
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44,5 ml/min. His mean blood pressure on admis-
sion and in consecutive measurements was 150/
/80 mmHg on triple therapy (ACE inhibitor — per-
indopril 10 mg, thiazide-like diuretic — indapami-
de 1,5 mg, calcium antagonist — amlodipine 5 mg).
CT scan confirmed aortic aneurysm and 80% ste-
nosis of the left renal artery (fig. 1). Maximal dia-
meters of aortic aneurysm was 5.8 × 5.4 cm, the
neck of the aneurysm measured 3 cm and did not
include the renal artery.
Because of a high level of perioperative risk (renal
insufficiency, prior myocardial infarction and
COPD), favorable anatomy and coexisting signifi-
cant RAS, simultaneous EVAR with PTRA was cho-
sen in the management of the patient. To decrease
the risk of a contrast-induced nephropathy, patient
was vigorously intravenously hydrated with 0,9% sa-
line before and after the procedure and a low-osmo-
lar nonionic contrast was used during the procedure.
The procedure was done under spinal anaesthesia.
Both common femoral arteries were exposed by sur-
gical dissection. The calibrated 5F type pigtail cathe-
ter was introduced into the aorta above the renal
artery through the left common femoral artery over
a hydrophilic guidewire 0.035 (Roadrunner: Cook
Ireland Ltd., Europe Shared Service Center, O’Hal-
loran Rd., National Technology Park, Limerick, Ire-
land) (fig. 2). At first stenosis of left renal artery was
treated. After performing the angioplasty, stent was
assembled on balloon, 6 mm in diameter and 12 mm
in length (Smart, Cordis Corp, NJ, USA), and im-
planted. After stent implantation digital subtraction
angiography (DSA) was performed to examine the
location. Subsequently the body of stent-graft (Cook
company Inc. USA Terumo Corp., Tokyo, Japan)
was introduced over a stiff Lunderquist 0.35 guide
through the right femoral artery, into the abdominal
aorta, and the covered part of stentgraft was positio-
ned below the renal arteries. Afterwards a guide
was introduced into the stent-graft by the left femo-
ral artery. Iliac part of prosthesis was introduced
into aorta through the Amplatz 0.35 guide. The
right arm of stent-graft was prolonged up to iliac
artery. Then, the arms of prosthesis were positio-
ned in the iliac common artery. Directly after stent-
grafting digital subtraction angiography (DSA) was
performed to examine the location and tightness of
the prosthesis (fig. 3).
 Follow-up after combined aortic and renal endova-
scular treatment consisted of a physical examination, la-
boratory studies including creatinine, estimated GFR,Figure 1. Angio CT before renal stent and stentgraft implantation
Figure 2. DSA image before renal stent and stentgraft implantation Figure 3. DSA image  after renal stent and stentgraft implantation
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and urea, and ultrasound duplex at 6, 12, 24 and
36 months. Due to renal dysfunction the use contrast-
enhanced CT was limited and performed at 12 and
36 months after endovascular treatment. At 12 months of
follow-up the patients laboratory studies showed creati-
nine 112,9 µmol/l , eGFR — 59 ml/min while at 36 mon-
ths: creatinine 99,1 µmol/l and eGFR — 68,7 ml/min.
Twelve months after endovascular repair the blood pres-
sure was 130/80 mmHg and a reduction of antihyperten-
sive drugs (perindopril 5 mg, indapamide 1,5 mg) was
possible. At 12 and 36 months after endovascular recon-
struction angioCT revealed patent renal artery stent wi-
thout evidence of in-stent restenosis and proper place-
ment aortic endograft without complications (fig. 4).
Discussion
When choosing between EVAR and open surgical
repair patient’s age, risk factors for perioperative mor-
bidity and mortality, anatomic factors and experien-
ce of the surgeon is usually taken into account [6, 7].
The classic indication for EVAR is elderly patient
with favourable anatomy who is at high level of pe-
rioperative risk. In recent years the numbers of abdo-
minal stent-graft placement have significantly incre-
ased [8, 9] and EVAR is offered also in low- or avera-
ge-risk patients who have no particular contraindi-
cations to conventional surgical treatment. EVAR
shows an early benefit in patients with preexisting
severe neurological, cardiovascular, pulmonary or re-
nal dysfunction [10]. For that reason it offers shorter
hospitalization and faster convalescence. The short-
-term observation of plain EVAR shows favourably
renal outcome compared to surgical treatment [11].
This advantage is not seen in longer than one-year
observation, when the outcomes are comparable [12].
The diagnosis of coexisting RAS causes the choice
of management even more difficult. Expert panel po-
sition statement on indication for revascularization
of renal artery stenosis in hypertensive patients pu-
blished after the results of the ASTRAL trial in 2009,
recommends an individualiazed approach to patients
with significant atherosclerotic RAS based on natu-
ral history of disease and other clinical data. The
angioplasty with stent is justified in patients with
significant RAS and severe, malignant and resistant
hypertension. The document only briefly mentions
that atherosclerotic RAS should be simultaneuosly
treated in case surgical repair of abdominal aorta in
vicinity of origins of renal arteries is performed. The-
re are no recommendation on how to manage a pa-
tient in case of endovascularar treatment of infrare-
nal AAA and coexisting significant RAS [13].
When treatment of both AAA and RAS is needed,
an important clinical question would be about timing
of both procedures — if they can be done simultane-
ously or should be separated in time. An individuali-
zed approach to such patient seems to be reasonable.
One of the major advantages of simultaneous treat-
ment is no need of another invasive procedure and
avoidance of risk of local complication connected with
gaining vascular access. Small series presented in the
literature have shown promising early results of si-
multaneous EVAR and renal stenting without incre-
asing the risk of type I endoleaks and of restenosis in
the renal stent in short-term follow up [11, 14]. Su-
prarenal fixation aortic endograft is safe procedure wi-
thout blood flow disorder on the renal artery stent and
impair kidney function [15]. In case the RAS was not
treated during EVAR with suprarenal fixation aortic
endograft, there are no contraindications to perform
angioplasty of RAS in the future [16]. The necessity of
angioplasty may be needed not only in patients with
already significant RAS, but also in case of natural
progression of previously insignificant RAS or not very
common, but possible situation when endograft mi-
grates and impairs blood flow in renal artery.
All patients after EVAR, with or without RAS, re-
quires regular follow-up [17]. Protocols vary, but
a typical schedule after uncomplicated EVAR consi-
sts of follow up one, six, and 12 months, and then
annually. Combined duplex ultrasound and CT scan
are generally accepted methods to check the position of
the graft, leak to the aneurysms sac and restenosis in
renal stent. CT scans often can be performed without
the necessity of intravenous contrast load.
Figure 4. Angio CT 36 month after renal stent and stentgraft im-
plantation
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Conclusions
Patients with coexisting RAS and AAA need an
individualized approach and often may be treated
simultaneously by EVAR and renal stenting. Presen-
ted strategy show promise to be a safe method witho-
ut adverse effect on renal artery stent patency or re-
nal function [18].
Summary
Abdominal aortic aneurysm (AAA) often coexists with re-
nal artery stenosis (RAS). Such patients need an individu-
alized approach in choice of treatment. Endovascular re-
pair of infrarenal AAA has become in recent years a gener-
ally accepted alternative to open surgery. In treatment of
RAS, percutaneous techniques have largely replaced surgi-
cal revascularization. In the article a case of patient witha
high level of perioperative risk and refractory hypertension
is presented, who was successfully treated with simultane-
ous endovascular repair of AAA and RAS.
key words: stenosis of renal artery, hypertension, abdominal
aortic aneurysm, stentgraft
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